Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Free Cash Flow (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Free Cash Flow for 9 consecutive years, with $41.8 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 24.76% to $41.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.5 million through Dec 2025, down 13.88% year-over-year, with the annual reading at $78.5 million for FY2025, 13.88% down from the prior year.
  • Free Cash Flow hit $41.8 million in Q4 2025 for Inspire Medical Systems, down from $58.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $72.9 million in Q3 2024 to a low of -$15.1 million in Q1 2025.
  • Historically, Free Cash Flow has averaged $8.0 million across 5 years, with a median of -$1.9 million in 2021.
  • Biggest five-year swings in Free Cash Flow: surged 1559.27% in 2022 and later tumbled 432.79% in 2025.
  • Year by year, Free Cash Flow stood at $1.1 million in 2021, then surged by 1559.27% to $18.5 million in 2022, then crashed by 50.18% to $9.2 million in 2023, then soared by 262.94% to $33.5 million in 2024, then increased by 24.76% to $41.8 million in 2025.
  • Business Quant data shows Free Cash Flow for INSP at $41.8 million in Q4 2025, $58.1 million in Q3 2025, and -$6.3 million in Q2 2025.